595 related articles for article (PubMed ID: 31897843)
1. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
[TBL] [Abstract][Full Text] [Related]
2. Progress toward liquid biopsies in pediatric solid tumors.
Weiser DA; West-Szymanski DC; Fraint E; Weiner S; Rivas MA; Zhao CWT; He C; Applebaum MA
Cancer Metastasis Rev; 2019 Dec; 38(4):553-571. PubMed ID: 31836951
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
4. Update on the types and usage of liquid biopsies in the clinical setting: a systematic review.
Arneth B
BMC Cancer; 2018 May; 18(1):527. PubMed ID: 29728089
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.
Bounajem MT; Karsy M; Jensen RL
Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088
[TBL] [Abstract][Full Text] [Related]
6. Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring.
Gelineau NU; van Barneveld A; Samim A; Van Zogchel L; Lak N; Tas ML; Matser Y; Mavinkurve-Groothuis AMC; van Grotel M; Zsiros J; van Eijkelenburg NKA; Knops RRG; van Ewijk R; Langenberg KPS; Krijger R; Hiemcke-Jiwa LS; Van Paemel R; Cornelli L; De Preter K; De Wilde B; Van Der Schoot E; Tytgat G
Front Oncol; 2023; 13():1209150. PubMed ID: 37664065
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
Mohanty A; Mohanty SK; Rout S; Pani C
Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature.
Shoda K; Saito R; Maruyama S; Furuya S; Akaike H; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
Surg Today; 2021 Jun; 51(6):849-861. PubMed ID: 32979121
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsies in pediatric oncology: opportunities and obstacles.
Sundby RT; Pan A; Shern JF
Curr Opin Pediatr; 2022 Feb; 34(1):39-47. PubMed ID: 34840249
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.
Gao Y; Zhou N; Liu J
Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160
[TBL] [Abstract][Full Text] [Related]
11. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy: the value of different bodily fluids.
Santos V; Freitas C; Fernandes MG; Sousa C; Reboredo C; Cruz-Martins N; Mosquera J; Hespanhol V; Campelo R
Biomark Med; 2022 Feb; 16(2):127-145. PubMed ID: 35073730
[TBL] [Abstract][Full Text] [Related]
13. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
Barlebo Ahlborn L; Østrup O
APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
[TBL] [Abstract][Full Text] [Related]
14. Urine-Based Liquid Biopsy for Nonurological Cancers.
Jain S; Lin SY; Song W; Su YH
Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
[TBL] [Abstract][Full Text] [Related]
15. Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.
Abbou SD; Shulman DS; DuBois SG; Crompton BD
Pediatr Blood Cancer; 2019 May; 66(5):e27595. PubMed ID: 30614191
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
von Bubnoff N
Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
[TBL] [Abstract][Full Text] [Related]
17. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics.
Sonmezler O; Boga I; Bisgin A
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
[TBL] [Abstract][Full Text] [Related]
18. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response.
Buccilli B; Rodriguez Molina MA; Redrovan Palomeque DP; Herrera Sabán CA; C Caliwag FM; Contreras Flores CJS; Abeysiriwardana CWJ; Diarte E; Arruarana VS; Calderon Martinez E
Cureus; 2024 Jan; 16(1):e51712. PubMed ID: 38313884
[TBL] [Abstract][Full Text] [Related]
20. [Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].
Perrier A; Hainaut P; Guenoun A; Nguyen DP; Lamy PJ; Guerber F; Troalen F; Denis JA; Boissan M
Bull Cancer; 2022 Feb; 109(2):170-184. PubMed ID: 35034786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
